Abstract
The relevance of immunotherapy in treatment of tumors of the genitourinary system is increasing every year, which is due to the emerging data of molecular genetic studies, changes in classifications and a large number of ongoing clinical studies.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have